The dry AMD treatment market is experiencing unprecedented growth, driven by increasing disease awareness, rising prevalence of age-related eye cond ...

During a live event, Neal E. Ready, MD, and participants discussed use of PD-L1 status in non–small cell lung cancer and ...

Trastuzumab deruxtecan plus pertuzumab showed significant improvement in PFS compared with taxane chemotherapy plus trastuzumab and pertuzumab across patients with HER2-positive metastatic breast ...

The pavilion, run by the Korea Trade-Investment Promotion Agency (KOTRA), features 58 companies in cooperation with five ...

Johnson & Johnson (JNJ), Abbvie (ABBV), Novo Nordisk (NVO), and Astrazeneca (AZN), are falling after President Trump said tariffs on the industry are coming "very soon." Chris Meekins, managing ...

The U.S. government is looking for ways to restrict the pharma sector’s direct-to-consumer advertising to make it more difficult and costly for companies to run advertisements directly targeting ...

Phase 2 trial results support Isa-KRd as a standard treatment option for patients with high-risk, newly diagnosed multiple myeloma, according to researchers.

During the Covid-19 pandemic, South African and Colombian civil society organisations initiated strategic litigation against their governments to gain transparency on confidential vaccine contracts ...

JNJ's Innovative Medicines unit shows a growth trend, defying Stelara LOE and the negative impact of the Part D redesign.

"We are honored to welcome Dr. Ekuta to our Life Sciences Strategic Advisory Board," said Girish Pashilkar, CEO of BP Logix. ...

Adding polatuzumab vedotin (Polivy) to standard-of-care treatment significantly improved overall survival (OS) in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), the phase ...

Recent collaborations highlight a growing interest in building a multiomics-based understanding of health and disease.